Tag Archives: Pierre Fabre

May, 2017

  • 24 May

    Pierre Fabre Buys Promising Assets from Igencia in the Field of Immuno-Oncology

    CASTRES, France–(BUSINESS WIRE)–Pierre Fabre, the 2nd largest French private Pharmaceutical group, today announced the signature of a definitive purchase agreement to acquire several assets from the biotechnology company Igenica Biotherapeutics, based in Burlingame, California, USA. The agreement includes innovative immunotherapies targeting immune checkpoints that may reverse the resistance to existing …

March, 2017

  • 22 March

    Pierre Fabre and H-Immune Partner on Immuno-Oncology Therapeutics

    CASTRES and PARIS, France March 21, 2017 – Pierre Fabre, the second largest privately held pharmaceutical company in France, and H-Immune SAS, an emerging biotechnology company focused on developing first in class immunotherapies for treatment of various cancers, today announced that they have entered into a strategic research partnership which …

November, 2016